Immunogenicity in xenogeneic scaffold generation

Antigen removal vs. decellularization

Maelene L. Wong, Leigh G. Griffiths

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

Decades of research have been undertaken towards the goal of tissue engineering using xenogeneic scaffolds. The primary advantages associated with use of xenogeneic tissue-derived scaffolds for in vitro development of replacement tissues and organs stem from the inherent extracellular matrix (ECM) composition and architecture. Native ECM possesses appropriate mechanical properties for physiological function of the biomaterial and signals for cell binding, growth and differentiation. Additionally, xenogeneic tissue is readily available. However, translation of xenogeneic scaffold-derived engineered tissues or organs into clinical therapies requires xenoantigenicity of the material to be adequately addressed prior to implantation. Failure to achieve this goal will result in a graft-specific host immune rejection response, jeopardizing in vivo survival of the resultant scaffold, tissue or organ. This review explores (i) the appropriateness of scaffold acellularity as an outcome measure for assessing reduction of the immunological barriers to the use of xenogeneic scaffolds for tissue engineering applications and (ii) the need for tissue engineers to strive for antigen removal during xenogeneic scaffold generation.

Original languageEnglish (US)
Pages (from-to)1806-1816
Number of pages11
JournalActa Biomaterialia
Volume10
Issue number5
DOIs
StatePublished - 2014

Fingerprint

Antigens
Scaffolds
Tissue
Tissue Scaffolds
Tissue Engineering
Extracellular Matrix
Scaffolds (biology)
Tissue engineering
Biocompatible Materials
Biomaterials
Grafts
Outcome Assessment (Health Care)
Transplants
Engineers
Growth
Mechanical properties
Research
Chemical analysis
Therapeutics

Keywords

  • Antigen removal
  • Decellularization
  • Extracellular matrix
  • Tissue engineering
  • Xenogeneic scaffold

ASJC Scopus subject areas

  • Biomaterials
  • Biomedical Engineering
  • Biotechnology
  • Biochemistry
  • Molecular Biology
  • Medicine(all)

Cite this

Immunogenicity in xenogeneic scaffold generation : Antigen removal vs. decellularization. / Wong, Maelene L.; Griffiths, Leigh G.

In: Acta Biomaterialia, Vol. 10, No. 5, 2014, p. 1806-1816.

Research output: Contribution to journalArticle

Wong, Maelene L. ; Griffiths, Leigh G. / Immunogenicity in xenogeneic scaffold generation : Antigen removal vs. decellularization. In: Acta Biomaterialia. 2014 ; Vol. 10, No. 5. pp. 1806-1816.
@article{470fbadd5ee54fe38d9da1b62ebefe5d,
title = "Immunogenicity in xenogeneic scaffold generation: Antigen removal vs. decellularization",
abstract = "Decades of research have been undertaken towards the goal of tissue engineering using xenogeneic scaffolds. The primary advantages associated with use of xenogeneic tissue-derived scaffolds for in vitro development of replacement tissues and organs stem from the inherent extracellular matrix (ECM) composition and architecture. Native ECM possesses appropriate mechanical properties for physiological function of the biomaterial and signals for cell binding, growth and differentiation. Additionally, xenogeneic tissue is readily available. However, translation of xenogeneic scaffold-derived engineered tissues or organs into clinical therapies requires xenoantigenicity of the material to be adequately addressed prior to implantation. Failure to achieve this goal will result in a graft-specific host immune rejection response, jeopardizing in vivo survival of the resultant scaffold, tissue or organ. This review explores (i) the appropriateness of scaffold acellularity as an outcome measure for assessing reduction of the immunological barriers to the use of xenogeneic scaffolds for tissue engineering applications and (ii) the need for tissue engineers to strive for antigen removal during xenogeneic scaffold generation.",
keywords = "Antigen removal, Decellularization, Extracellular matrix, Tissue engineering, Xenogeneic scaffold",
author = "Wong, {Maelene L.} and Griffiths, {Leigh G.}",
year = "2014",
doi = "10.1016/j.actbio.2014.01.028",
language = "English (US)",
volume = "10",
pages = "1806--1816",
journal = "Acta Biomaterialia",
issn = "1742-7061",
publisher = "Elsevier BV",
number = "5",

}

TY - JOUR

T1 - Immunogenicity in xenogeneic scaffold generation

T2 - Antigen removal vs. decellularization

AU - Wong, Maelene L.

AU - Griffiths, Leigh G.

PY - 2014

Y1 - 2014

N2 - Decades of research have been undertaken towards the goal of tissue engineering using xenogeneic scaffolds. The primary advantages associated with use of xenogeneic tissue-derived scaffolds for in vitro development of replacement tissues and organs stem from the inherent extracellular matrix (ECM) composition and architecture. Native ECM possesses appropriate mechanical properties for physiological function of the biomaterial and signals for cell binding, growth and differentiation. Additionally, xenogeneic tissue is readily available. However, translation of xenogeneic scaffold-derived engineered tissues or organs into clinical therapies requires xenoantigenicity of the material to be adequately addressed prior to implantation. Failure to achieve this goal will result in a graft-specific host immune rejection response, jeopardizing in vivo survival of the resultant scaffold, tissue or organ. This review explores (i) the appropriateness of scaffold acellularity as an outcome measure for assessing reduction of the immunological barriers to the use of xenogeneic scaffolds for tissue engineering applications and (ii) the need for tissue engineers to strive for antigen removal during xenogeneic scaffold generation.

AB - Decades of research have been undertaken towards the goal of tissue engineering using xenogeneic scaffolds. The primary advantages associated with use of xenogeneic tissue-derived scaffolds for in vitro development of replacement tissues and organs stem from the inherent extracellular matrix (ECM) composition and architecture. Native ECM possesses appropriate mechanical properties for physiological function of the biomaterial and signals for cell binding, growth and differentiation. Additionally, xenogeneic tissue is readily available. However, translation of xenogeneic scaffold-derived engineered tissues or organs into clinical therapies requires xenoantigenicity of the material to be adequately addressed prior to implantation. Failure to achieve this goal will result in a graft-specific host immune rejection response, jeopardizing in vivo survival of the resultant scaffold, tissue or organ. This review explores (i) the appropriateness of scaffold acellularity as an outcome measure for assessing reduction of the immunological barriers to the use of xenogeneic scaffolds for tissue engineering applications and (ii) the need for tissue engineers to strive for antigen removal during xenogeneic scaffold generation.

KW - Antigen removal

KW - Decellularization

KW - Extracellular matrix

KW - Tissue engineering

KW - Xenogeneic scaffold

UR - http://www.scopus.com/inward/record.url?scp=84898057987&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898057987&partnerID=8YFLogxK

U2 - 10.1016/j.actbio.2014.01.028

DO - 10.1016/j.actbio.2014.01.028

M3 - Article

VL - 10

SP - 1806

EP - 1816

JO - Acta Biomaterialia

JF - Acta Biomaterialia

SN - 1742-7061

IS - 5

ER -